{"id":289238,"date":"2026-10-06T11:25:04","date_gmt":"2026-10-06T05:55:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=289238"},"modified":"2026-10-06T11:25:04","modified_gmt":"2026-10-06T05:55:04","slug":"why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/","title":{"rendered":"Kilitch Drugs (India) Ltd. (KILITCH) Share Price Rise Streak extends to second straight session"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/kilitch\/kilitch-drugs-(india)-ltd-share-price-today\">Kilitch Drugs (India) Ltd. (KILITCH)<\/a> share price rose to Rs 254 today, up 8.78% from the previous close. Market cap was Rs 755.34 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Kilitch Drugs (India) Ltd. Share Price is in its second straight session of gains, with the streak up 17.57% from Rs 216.05. The latest move lifted the stock to Rs 254, but the confirmed data does not establish a company-specific cause.<\/p>\n<p>Kilitch Drugs (India) Ltd. Share Price matters today because the company\u2019s market capitalisation is Rs 755.34 crore and the move is part of a consecutive pattern rather than a single-session jump. For readers tracking Kilitch Drugs (India) Ltd. Share Price Rise Streak, the key question is how the run fits with valuation, sector positioning and peer comparisons.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Kilitch_Drugs_India_Ltd_Share_Price_Rise_Streak_Consecutive_Gain_Analysis\" title=\"Kilitch Drugs (India) Ltd. Share Price Rise Streak: Consecutive Gain Analysis\">Kilitch Drugs (India) Ltd. Share Price Rise Streak: Consecutive Gain Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#What_the_Consecutive_Gains_Show\" title=\"What the Consecutive Gains Show\">What the Consecutive Gains Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Kilitch_Drugs_India_Ltd_KILITCH_Fundamental_Analysis\" title=\"Kilitch Drugs (India) Ltd. (KILITCH) Fundamental Analysis\">Kilitch Drugs (India) Ltd. (KILITCH) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Why_Investors_Are_Watching_Kilitch_Drugs_India_Ltd\" title=\"Why Investors Are Watching Kilitch Drugs (India) Ltd.\">Why Investors Are Watching Kilitch Drugs (India) Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#About_Kilitch_Drugs_India_Ltd\" title=\"About Kilitch Drugs (India) Ltd.\">About Kilitch Drugs (India) Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#What_is_Kilitch_Drugs_India_Ltd_Share_Price_today\" title=\"What is Kilitch Drugs (India) Ltd. Share Price today?\">What is Kilitch Drugs (India) Ltd. Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Why_is_Kilitch_Drugs_India_Ltd_Share_Price_rising_today\" title=\"Why is Kilitch Drugs (India) Ltd. Share Price rising today?\">Why is Kilitch Drugs (India) Ltd. Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#How_much_has_Kilitch_Drugs_India_Ltd_Share_Price_gained_in_the_streak\" title=\"How much has Kilitch Drugs (India) Ltd. Share Price gained in the streak?\">How much has Kilitch Drugs (India) Ltd. Share Price gained in the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#What_was_Kilitch_Drugs_India_Ltd_Share_Price_previous_close\" title=\"What was Kilitch Drugs (India) Ltd. Share Price previous close?\">What was Kilitch Drugs (India) Ltd. Share Price previous close?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#How_does_Kilitch_Drugs_India_Ltd_Share_Price_compare_with_the_sector_benchmark\" title=\"How does Kilitch Drugs (India) Ltd. Share Price compare with the sector benchmark?\">How does Kilitch Drugs (India) Ltd. Share Price compare with the sector benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#What_is_the_market_capitalisation_of_Kilitch_Drugs_India_Ltd\" title=\"What is the market capitalisation of Kilitch Drugs (India) Ltd.?\">What is the market capitalisation of Kilitch Drugs (India) Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#How_should_investors_read_Kilitch_Drugs_India_Ltd_Share_Price_Rise_Streak\" title=\"How should investors read Kilitch Drugs (India) Ltd. Share Price Rise Streak?\">How should investors read Kilitch Drugs (India) Ltd. Share Price Rise Streak?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-consecutive-price-rise-2026\/#Track_Kilitch_Drugs_India_Ltd_Share_Price_on_Univest\" title=\"Track Kilitch Drugs (India) Ltd. Share Price on Univest\">Track Kilitch Drugs (India) Ltd. Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Kilitch_Drugs_India_Ltd_Share_Price_Rise_Streak_Consecutive_Gain_Analysis\"><\/span><strong>Kilitch Drugs (India) Ltd. Share Price Rise Streak: Consecutive Gain Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kilitch Drugs (India) Ltd. Share Price rose to Rs 254 in its second straight session, taking the cumulative streak gain to 17.57% from Rs 216.05. Univest figures confirm the price action, but they do not point to a specific company trigger. The move keeps Kilitch Drugs (India) Ltd. Share Price in focus as a streak-driven stock rather than a one-day spike.<\/p>\n<p>For readers, the pattern is more important than a single print. Kilitch Drugs (India) Ltd. Share Price now reflects two consecutive higher closes, which can change how the market reads the stock\u2019s valuation and positioning within Healthcare. The company\u2019s market capitalisation stands at Rs 755.34 crore, so the streak should be read alongside business fundamentals, sector benchmarks and peer numbers already visible in the latest Univest figures.<\/p>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) rose to Rs 254 from the previous close of Rs 233.5, a move of Rs 20.5 or 8.78%. The stock opened at Rs 243.9, reached a high of Rs 254.85, recorded a low of Rs 238.15.<\/p>\n<p>Kilitch Drugs (India) Ltd. Share Price stayed near the top of that range, with the latest print just below the day\u2019s high. The gap between the open and the current level shows a firm intraday rise, but the point for investors is simpler: the stock did not just rise once, it followed that with another higher close. Market capitalisation stood at Rs 755.34 crore, keeping Kilitch Drugs (India) Ltd. Share Price in the lower end of the tracked industry\u2019s size band. The next section turns to the earnings and valuation context behind the streak.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Consecutive_Gains_Show\"><\/span><strong>What the Consecutive Gains Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The consecutive gains in Kilitch Drugs (India) Ltd. Share Price show a cumulative 17.57% move across two sessions, starting from Rs 216.05. That is the cleanest way to read the streak: the latest price rise is not isolated, because the stock has now printed two higher closes in a row. According to latest Univest data, the pattern itself is confirmed, while the reason behind it is not.<\/p>\n<p>For a reader of Kilitch Drugs (India) Ltd. Share Price Rise Streak, the useful lens is comparative. The first session laid the base, and the second session added more to the move. That makes the price action more notable than a one-off gain, even though the data does not support a catalyst claim. The next sections therefore focus on whether the company\u2019s valuation and operating ratios add context to the move.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Kilitch_Drugs_India_Ltd_KILITCH_Fundamental_Analysis\"><\/span><strong>Kilitch Drugs (India) Ltd. (KILITCH) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 755.34 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 8.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 80.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) fundamental metrics show P\/E 27.16x, P\/B 2.9x, ROE 12.26%, ROCE 14.5%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Kilitch Drugs (India) Ltd. has a market capitalisation of Rs 755.34 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 27.16x, P\/B at 2.9x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.26% and ROCE of 14.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 8.6, book value per share of Rs 80.45, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 31.79x, median ROE of 11.73%, median ROCE of 13.63%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.58x to 668.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.73%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 755.34 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 812.84 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) has a P\/E ratio of 27.16x, which is below the benchmark median of 31.79x, a difference of -14.56%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) has a ROE of 12.26%, which is above the benchmark median of 11.73%, a difference of +4.52%. Kilitch Drugs (India) Ltd. (KILITCH) has a ROCE of 14.5%, which is above the benchmark median of 13.63%, a difference of +6.38%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,34,279.63<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">35.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,737.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,81,129.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">82.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,239.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,08,808.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) has a P\/E ratio of 27.16x compared with the displayed peer median of 35.35x. The comparison is relative and should not be read as a recommendation. Its ROE of 12.26% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Kilitch Drugs (India) Ltd. (KILITCH) has a market capitalisation of Rs 755.34 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Kilitch_Drugs_India_Ltd\"><\/span><strong>Why Investors Are Watching Kilitch Drugs (India) Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Kilitch Drugs (India) Ltd. Share Price has printed a second straight higher close, with a 17.57% cumulative streak move from Rs 216.05.<\/li>\n<li>The latest price action shows Rs 254 versus the previous close of Rs 233.5, which keeps Kilitch Drugs (India) Ltd. Share Price firmly in focus.<\/li>\n<li>The valuation backdrop is readable: P\/E of 27.16, P\/B of 2.9, ROE of 12.26% and ROCE of 14.5%.<\/li>\n<li>In the Healthcare sector, Kilitch Drugs (India) Ltd. Share Price sits below the industry median market cap and near the industry median P\/B.<\/li>\n<li>The streak matters because the market has rerated the stock through price, while the business metrics themselves have not changed across the run.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Kilitch_Drugs_India_Ltd\"><\/span><strong>About Kilitch Drugs (India) Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kilitch Drugs (India) Ltd. operates in Healthcare and the Pharmaceuticals &amp; Drugs industry. For readers tracking Kilitch Drugs (India) Ltd. Share Price, that matters because the company\u2019s valuation and comparison set should be read within a regulated, formulation-led part of the market. The company\u2019s stock price movement is therefore not just a trading statistic; it also reflects how the market is viewing a smaller healthcare business against a wider peer group.<\/p>\n<p>Kilitch Drugs (India) Share Price Rise Streak needs to be read in that business context. The company\u2019s market capitalisation, earnings per share and book value per share show a listed healthcare name with measurable profitability and asset backing, while dividend yield is 0. That means the present discussion is mainly about price, earnings and valuation rather than payout support. Univest data helps place the share price move inside this broader operating frame.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Kilitch_Drugs_India_Ltd_Share_Price_today\"><\/span><strong>What is Kilitch Drugs (India) Ltd. Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs (India) Ltd. Share Price was Rs 254 in the latest update, up 8.78% from the previous close of Rs 233.5. The move extends the stock\u2019s second straight session of higher closes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Kilitch_Drugs_India_Ltd_Share_Price_rising_today\"><\/span><strong>Why is Kilitch Drugs (India) Ltd. Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Univest figures confirm the price action, but they do not point to a specific company trigger. The stock rose to Rs 254, and the streak now totals a 17.57% cumulative gain across two sessions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_has_Kilitch_Drugs_India_Ltd_Share_Price_gained_in_the_streak\"><\/span><strong>How much has Kilitch Drugs (India) Ltd. Share Price gained in the streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative streak gain is 17.57%, starting from Rs 216.05. That makes the current move a two-session pattern of higher closes rather than a single-day price rise. The previous close was Rs 233.5.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Kilitch_Drugs_India_Ltd_Share_Price_previous_close\"><\/span><strong>What was Kilitch Drugs (India) Ltd. Share Price previous close?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The previous close was Rs 233.5. The stock traded above that level at Rs 254, which means the latest session added Rs 20.5 to the share price. The stock moved 8.78% so far today.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Kilitch_Drugs_India_Ltd_Share_Price_compare_with_the_sector_benchmark\"><\/span><strong>How does Kilitch Drugs (India) Ltd. Share Price compare with the sector benchmark?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the same industry, Kilitch Drugs (India) Ltd. Share Price sits below the median P\/E of 31.79 and matches the median P\/B of 2.9. Its ROE and ROCE are also above the benchmark medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Kilitch_Drugs_India_Ltd\"><\/span><strong>What is the market capitalisation of Kilitch Drugs (India) Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation is Rs 755.34 crore. That places Kilitch Drugs (India) Ltd. Share Price below the industry median market cap of Rs 812.84 crore in the same industry benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_should_investors_read_Kilitch_Drugs_India_Ltd_Share_Price_Rise_Streak\"><\/span><strong>How should investors read Kilitch Drugs (India) Ltd. Share Price Rise Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The streak shows two consecutive higher closes and a 17.57% cumulative move from Rs 216.05. Investors can read it as a price pattern supported by valuation and sector context, not by a stated catalyst.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is Kilitch Drugs (India) Ltd. Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs (India) Ltd. Share Price was Rs 254 in the latest update, up 8.78% from the previous close of Rs 233.5. The move extends the stock\u2019s second straight session of higher closes.\"}},{\"@type\":\"Question\",\"name\":\"Why is Kilitch Drugs (India) Ltd. Share Price rising today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Univest figures confirm the price action, but they do not point to a specific company trigger. The stock rose to Rs 254, and the streak now totals a 17.57% cumulative gain across two sessions.\"}},{\"@type\":\"Question\",\"name\":\"How much has Kilitch Drugs (India) Ltd. Share Price gained in the streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative streak gain is 17.57%, starting from Rs 216.05. That makes the current move a two-session pattern of higher closes rather than a single-day price rise. The previous close was Rs 233.5.\"}},{\"@type\":\"Question\",\"name\":\"What was Kilitch Drugs (India) Ltd. Share Price previous close?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The previous close was Rs 233.5. The stock traded above that level at Rs 254, which means the latest session added Rs 20.5 to the share price. The stock moved 8.78% so far today.\"}},{\"@type\":\"Question\",\"name\":\"How does Kilitch Drugs (India) Ltd. Share Price compare with the sector benchmark?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In the same industry, Kilitch Drugs (India) Ltd. Share Price sits below the median P\/E of 31.79 and matches the median P\/B of 2.9. Its ROE and ROCE are also above the benchmark medians.\"}},{\"@type\":\"Question\",\"name\":\"What is the market capitalisation of Kilitch Drugs (India) Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The market capitalisation is Rs 755.34 crore. That places Kilitch Drugs (India) Ltd. Share Price below the industry median market cap of Rs 812.84 crore in the same industry benchmark.\"}},{\"@type\":\"Question\",\"name\":\"How should investors read Kilitch Drugs (India) Ltd. Share Price Rise Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The streak shows two consecutive higher closes and a 17.57% cumulative move from Rs 216.05. Investors can read it as a price pattern supported by valuation and sector context, not by a stated catalyst.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Kilitch_Drugs_India_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Kilitch Drugs (India) Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/kilitch\/kilitch-drugs-(india)-ltd-share-price-today\">Kilitch Drugs (India) Ltd. (KILITCH) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Kilitch Drugs (India) Ltd. Share Price can be tracked on Univest for live price, valuation ratios, 52-week levels and market insights in one place. For readers following Kilitch Drugs (India) Ltd. Share Price Rise Streak, that makes it easier to monitor how the stock behaves after a two-session run and how the fundamentals stack up.<\/p>\n<p>Kilitch Drugs (India) Share Price analysis on Univest can be read alongside market capitalisation, P\/E, P\/B, ROE, ROCE, EPS and book value so that the price move stays connected to the company\u2019s underlying financial profile. The platform also keeps the stock context clear without forcing a recommendation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kilitch Drugs (India) Ltd. Share Price rises to Rs 254, marking an 8.78% rise today. Market cap stands at Rs 755.34 crore.<\/p>\n","protected":false},"author":35,"featured_media":289236,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-289238","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["289236"],"rank_math_title":["Kilitch Drugs (India) Ltd. Share Price Rise Streak and"],"rank_math_description":["Kilitch Drugs (India) Ltd. Share Price rose again in a second straight session. Read the price move, valuation ratios, sector context and peer comparison."],"rank_math_focus_keyword":["Kilitch Drugs (India) Ltd. Share Price Rise Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Kilitch_Drugs_India_Ltd_KILITCH_Share_Price_Rise_Streak_extends_to_second_straight_session_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/289238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=289238"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/289238\/revisions"}],"predecessor-version":[{"id":289239,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/289238\/revisions\/289239"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/289236"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=289238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=289238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=289238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}